Treatment with tralokinumab improves health-related quality of life in adult patients with moderate to severe atopic dermatitis: results from a Phase 2b, randomised, double-blind, placebo-controlled study

2018 ◽  
Vol 2 ◽  
pp. S64
Author(s):  
Jonathan I Silverberg ◽  
Nana Kragh ◽  
Emma Guttman-Yassky ◽  
Andreas Wollenberg

Abstract not available. Disclosures: Study sponsored by LEO Pharma. Copyright 2018 SKIN

Sign in / Sign up

Export Citation Format

Share Document